Cargando…

Role of the Gut in Diabetic Dyslipidemia

Type 2 diabetes (T2D) is associated with increased risk of cardiovascular disease (CVD). In insulin resistant states such as the metabolic syndrome, overproduction and impaired clearance of liver-derived very-low-density lipoproteins and gut-derived chylomicrons (CMs) contribute to hypertriglyceride...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stahel, Priska, Xiao, Changting, Nahmias, Avital, Lewis, Gary F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083132/ https://www.ncbi.nlm.nih.gov/pubmed/32231641 http://dx.doi.org/10.3389/fendo.2020.00116

Ejemplares similares

Emerging Role of Lymphatics in the Regulation of Intestinal Lipid Mobilization
por: Xiao, Changting, et al.
Publicado: (2020)

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor
por: Nahmias, Avital, et al.
Publicado: (2020)

Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms
por: Xiao, Changting, et al.
Publicado: (2018)

Assessment of lipid response to acute olanzapine administration in healthy adults
por: Nahmias, Avital, et al.
Publicado: (2020)

Gut microbiota is a potential goalkeeper of dyslipidemia
por: Lei, Lirong, et al.
Publicado: (2022)

Of the milk sugars, galactose, but not prebiotic galacto-oligosaccharide, improves insulin sensitivity in male Sprague-Dawley rats
por: Stahel, Priska, et al.
Publicado: (2017)

Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives
por: Rao, Hussain, et al.
Publicado: (2021)

Oral Glucose Mobilizes Triglyceride Stores From the Human Intestine
por: Xiao, Changting, et al.
Publicado: (2018)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

Zebrafish Models for Dyslipidemia and Atherosclerosis Research
por: Schlegel, Amnon
Publicado: (2016)

Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
por: Fang, Qing, et al.
Publicado: (2021)

Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review
por: Vukovic, Rade, et al.
Publicado: (2019)

Dyslipidemia and 10-year diabetes incidence in Japanese people: Population-based Panasonic cohort study 9
por: Kobayashi, Genki, et al.
Publicado: (2022)

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
por: Bage, Isaac J, et al.
Publicado: (2023)

Erratum: Dyslipidemia and 10-year diabetes incidence in Japanese people: Population-based Panasonic cohort study 9
Publicado: (2022)

The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis
por: Dedrick, Sandra, et al.
Publicado: (2020)

Effect of Washed Microbiota Transplantation on Patients With Dyslipidemia in South China
por: Liang, Fenfen, et al.
Publicado: (2022)

The Role of Gut Microflora and the Cholinergic Anti-inflammatory Neuroendocrine System in Diabetes Mellitus
por: Parekh, Parth J., et al.
Publicado: (2016)

ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study
por: Íñiguez, María, et al.
Publicado: (2021)

Impact of dyslipidemia on the cumulative pregnancy outcomes after first ovarian stimulation
por: Jiang, Xue, et al.
Publicado: (2022)

Corrigendum: ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study
por: Íñiguez, María, et al.
Publicado: (2021)

Favorable Genotypes of Type III Interferon Confer Risk of Dyslipidemia in the Population With Obesity
por: Xu, Tiantian, et al.
Publicado: (2022)

Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms
por: Zhou, He, et al.
Publicado: (2020)

Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study
por: Yue, Jiang, et al.
Publicado: (2021)

Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study
por: Zhang, Guangyang, et al.
Publicado: (2022)

Dyslipidemia Risk in Thyroid Cancer Patients: A Nationwide Population-Based Cohort Study
por: Song, Youhyun, et al.
Publicado: (2022)

Association Between Dyslipidemia and Helicobacter Pylori Infection
por: Hayes Dorado, Juan Pablo
Publicado: (2021)

Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves’ Ophthalmopathy
por: Wang, Yan, et al.
Publicado: (2022)

The critical role of gut microbiota in obesity
por: Cheng, Zilu, et al.
Publicado: (2022)

Effectiveness of Remotely Delivered Interventions to Simultaneously Optimize Management of Hypertension, Hyperglycemia and Dyslipidemia in People With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Fernando, Malindu E., et al.
Publicado: (2022)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
por: Silva, Ygor Parladore, et al.
Publicado: (2020)

Corrigendum: Effectiveness of Remotely Delivered Interventions to Simultaneously Optimize Management of Hypertension, Hyperglycemia and Dyslipidemia in People With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Fernando, Malindu E., et al.
Publicado: (2022)

Aberrant Gut-To-Brain Signaling in Irritable Bowel Syndrome - The Role of Bile Acids
por: Ní Dhonnabháín, Róisín, et al.
Publicado: (2021)

P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance
por: Coccurello, Roberto, et al.
Publicado: (2020)

Chronic-binge ethanol feeding aggravates systemic dyslipidemia in Ldlr (-/-) mice, thereby accelerating hepatic fibrosis
por: Hoebinger, Constanze, et al.
Publicado: (2023)

Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Al Ghadeer, Hussain A, et al.
Publicado: (2021)

A Review of COVID-19 in Relation to Metabolic Syndrome: Obesity, Hypertension, Diabetes, and Dyslipidemia
por: Makhoul, Elias, et al.
Publicado: (2022)

Editorial: Understanding the role of gut hormones, microbiota, and miRNAs in metabolic regulation and glucose homeostasis in obesity and type-2-diabetes
por: Matz, Lisa M., et al.
Publicado: (2023)

Roles of gut microbiota and metabolites in overweight and obesity of children
por: Zhang, Shengan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a5lkg7keikhv5fkbi97mn0ast2